Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$1.65B |
| 2 |
GE Aerospace
GE
|
+$949M |
| 3 |
Lam Research
LRCX
|
+$564M |
| 4 |
KLA
KLAC
|
+$562M |
| 5 |
Cloudflare
NET
|
+$483M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.33B |
| 2 |
ServiceNow
NOW
|
+$984M |
| 3 |
Snowflake
SNOW
|
+$822M |
| 4 |
NVIDIA
NVDA
|
+$747M |
| 5 |
CrowdStrike
CRWD
|
+$712M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.45% |
| 2 | Communication Services | 14.46% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Healthcare | 9.16% |
| 5 | Industrials | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Cipher Digital
CIFR
$7.98B
| $32.4M | 0.02% |
2,519,281
+824,618
| +49% | +$13.1M |
|
277
CG Oncology
CGON
$6.37B
| $32.2M | 0.02% |
476,136
+193,630
| +69% | +$11M |
|
278
MasTec
MTZ
$21.8B
| $32M | 0.02% |
99,486
-3,370
| -3% | -$912K |
|
279
Nicolet Bankshares
NIC
$3.65B
| $31.8M | 0.02% |
+213,927
| New | +$31.1M |
|
280
Tandem Diabetes Care
TNDM
$1.34B
| $31.8M | 0.02% |
1,658,448
-362,928
| -18% | -$7.89M |
|
|
INN
281
Summit Hotel Properties
INN
$737M
| $31.3M | 0.02% |
7,081,569
+140,495
| +2% | +$630K |
|
282
MPLX
MPLX
$61.1B
| $31.1M | 0.02% |
545,070
-125,257
| -19% | -$7.1M |
|
|
GRDN
283
Guardian Pharmacy Services
GRDN
$2.57B
| $31M | 0.02% |
822,784
+706,823
| +610% | +$23.1M |
|
284
Energy Transfer Partners
ET
$70.7B
| $30.6M | 0.02% |
1,584,039
+69,327
| +5% | +$1.27M |
|
285
Analog Devices
ADI
$184B
| $30.3M | 0.02% |
95,128
+90,962
| +2,183% | +$28.9M |
|
286
Revolution Medicines
RVMD
$41.8B
| $29.9M | 0.02% |
307,377
+2,117
| +0.7% | +$214K |
|
287
JFrog
FROG
$10.4B
| $29M | 0.02% |
618,669
+80,225
| +15% | +$3.94M |
|
288
Futu Holdings
FUTU
$15.6B
| $28.9M | 0.02% |
211,509
+50,229
| +31% | +$7.81M |
|
289
Twist Bioscience
TWST
$7B
| $28.8M | 0.02% |
605,188
-13,745
| -2% | -$616K |
|
290
Plains GP Holdings
PAGP
$4.98B
| $27.4M | 0.02% |
1,126,827
-14,875
| -1% | -$325K |
|
291
Enterprise Products Partners
EPD
$81.1B
| $27.2M | 0.02% |
718,543
+31,447
| +5% | +$1.11M |
|
292
Olema Pharmaceuticals
OLMA
$1.01B
| $27.2M | 0.02% |
1,822,123
+858,126
| +89% | +$19.1M |
|
293
Estee Lauder
EL
$31.6B
| $26.9M | 0.02% |
374,831
+60,275
| +19% | +$6.16M |
|
294
Horizon Bancorp
HBNC
$1.06B
| $26.6M | 0.02% |
1,605,798
+363,433
| +29% | +$6.22M |
|
|
TERN
295
DELISTED
Terns Pharmaceuticals
TERN
| $26.4M | 0.02% |
+501,419
| New | +$20.6M |
|
296
Celcuity
CELC
$4.56B
| $26.4M | 0.02% |
231,140
+1,436
| +0.6% | +$157K |
|
297
Sotera Health
SHC
$5.13B
| $26.3M | 0.02% |
1,836,746
+435,384
| +31% | +$7.23M |
|
298
Agilysys
AGYS
$3.1B
| $26M | 0.02% |
365,580
+143,789
| +65% | +$12.5M |
|
|
MWH
299
SOLV Energy Inc
MWH
$5.94B
| $26M | 0.02% |
+864,823
| New | +$25.7M |
|
300
XP
XP
$8.9B
| $25.8M | 0.02% |
1,357,313
-381,576
| -22% | -$7.37M |
|
Similar funds
Jennison Associates's Q1 2026 Portfolio in Review
As of Q1 2026, Jennison Associates held 653 positions worth $145B, down 13% from $167B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Jennison Associates withdrew a net $7.46B in Q1 2026, closing 91 positions and reducing 274 holdings. Its most notable exit was Sea Limited, an estimated $207M position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 42% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in Palantir worth $1.57B.
- Jennison Associates's largest Q1 2026 buy was Palantir: 10,760,942 shares worth $1.57B.
- Jennison Associates added most to GE Aerospace in Q1 2026, an estimated $949M increase.
- Jennison Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.33B.
- Jennison Associates fully exited Sea Limited in Q1 2026, selling an estimated $207M.
- Jennison Associates's ten largest holdings make up 46% of its $145B portfolio in Q1 2026.
- Jennison Associates opened 79 new positions and closed 91 in Q1 2026.
- Jennison Associates's portfolio value fell 13% quarter-over-quarter to $145B.
Based on Jennison Associates's 13F filing for Q1 2026, filed 6 May 2026.